Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021

SELL
$37.26 - $67.74 $745,200 - $1.35 Million
-20,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$45.01 - $65.47 $900,200 - $1.31 Million
20,000 New
20,000 $1.18 Million
Q3 2020

Nov 13, 2020

SELL
$35.79 - $48.81 $1.79 Million - $2.44 Million
-50,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$24.95 - $48.38 $1.25 Million - $2.42 Million
50,000 New
50,000 $2.42 Million

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $849M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Sivik Global Healthcare LLC Portfolio

Follow Sivik Global Healthcare LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sivik Global Healthcare LLC with notifications on news.